Vlad Coric - Oct 5, 2022 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Oct 5, 2022
Transactions value $
$5,009,425
Form type
4
Date filed
10/6/2022, 07:20 PM
Previous filing
Oct 12, 2022
Next filing
Oct 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Purchase $647K +73.3K +29.43% $8.82 322K Oct 5, 2022 By: The Vladimir Coric Family Trust F1, F2
transaction BHVN Common Shares Purchase $342K +34.5K +10.7% $9.90 357K Oct 5, 2022 By: The Vladimir Coric Family Trust F2, F3
transaction BHVN Common Shares Purchase $876K +80.9K +22.66% $10.83 438K Oct 5, 2022 By: The Vladimir Coric Family Trust F2, F4
transaction BHVN Common Shares Purchase $643K +54.3K +12.41% $11.83 492K Oct 5, 2022 By: The Vladimir Coric Family Trust F2, F5
transaction BHVN Common Shares Purchase $644K +73K +46.57% $8.82 230K Oct 5, 2022 By: The Vladimir Coric Marital Trust F2, F6
transaction BHVN Common Shares Purchase $341K +34.5K +15% $9.89 264K Oct 5, 2022 By: The Vladimir Coric Marital Trust F2, F7
transaction BHVN Common Shares Purchase $872K +80.6K +30.51% $10.82 345K Oct 5, 2022 By: The Vladimir Coric Marital Trust F2, F4
transaction BHVN Common Shares Purchase $619K +52.5K +15.23% $11.79 397K Oct 5, 2022 By: The Vladimir Coric Marital Trust F2, F8
transaction BHVN Common Shares Purchase $25.9K +2.1K +0.53% $12.35 399K Oct 5, 2022 By: The Vladimir Coric Marital Trust F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.27 - $9.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2 These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.32 - $10.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.32 - $11.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F5 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.32 - $12.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F6 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.30 - $9.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F7 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.31 - $10.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F8 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.32 - $12.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F9 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.34 - $12.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.